Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 778.070
- +6.070+0.79%
Close Jan 2 16:00 ET
- 777.905
- -0.165-0.02%
Post 17:29 ET
738.63BMarket Cap84.12P/E (TTM)
787.000High771.770Low1.94MVolume780.590Open772.000Pre Close1.51BTurnover0.21%Turnover Ratio134.15P/E (Static)949.32MShares970.91652wk High51.87P/B737.05BFloat Cap605.62252wk Low5.03Dividend TTM947.28MShs Float970.916Historical High0.65%Div YieldTTM1.97%Amplitude5.278Historical Low779.142Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Jon R. Moeller
- Independent Director
- --
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Ralph Alvarez
- Independent Director
- 336.00K
- Katherine Baicker
- Independent Director
- 336.00K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Jamere Jackson
- Independent Director
- 345.00K
- Jon Erik Fyrwald
- Independent Director
- 344.88K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
